June 3rd, 2016
On June 3rd, the Foundation announced the Prix Galien Belgium results for 2016:
- Connexin hemichannels as druggable targets for brain and cardiovascular disease
- Dr De Bock Marijke, Dr Decrock Elke and Dr Wang Nan – Universiteit Gent
- Nivolumab, OPDIVO®, BMS Belgium & Luxembourg
- Pembrolizumab KEYTRUDA® MSD Belgium and Luxembourg
- S-ICD EMBLEM Pierre Chauvineau Vice President Rhythm Management EMEA, Boston Scientific
The gala took place at BOZAR, under the presidency of M. Kris PEETERS, Vice-First Minister et Minister of Employment, Economy and Consumer Affairs, for Foreign Trade. M. Jo De COCK, General Manager National Institute for Health and Disability Insurance also attended the ceremony.
For more information, you may contact Ms. Isabelle SPETTANTE at isabelle.spettante@roularta.be, or, www.prixgalien-galenusprijs.be
Please enjoy moments from the Belgian awarding ceremony by clicking on the the following videos:
05/07/2016
